a revisit to anorectal malignant melanoma (armm) joint hospital surgical grand round 8 nov 2014 dr...
TRANSCRIPT
![Page 1: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/1.jpg)
A Revisit to AnorectalMalignant Melanoma (ARMM)
Joint Hospital Surgical Grand Round
8 Nov 2014
Dr Jessie Chan
Pamela Youde Nethersole Eastern Hospital
![Page 2: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/2.jpg)
Outline
Introduction Epidemiology Presentation Investigations Staging Prognosis
Treatment Surgery Adjuvant therapy
![Page 3: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/3.jpg)
Introduction
Rare neoplasm
First reported by Moore in 1857
Distinct biological and clinical entity from cutaneous melanoma with worse prognosis
No clear etiology elucidated
Arised from melanocytes distal to dentate line and extend proximally to rectum
Arised directly from melanocytes which present rarely in the mucosal epithelium of proximal anus or distal rectum
![Page 4: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/4.jpg)
ARMM
<1% of all malignant melanomas
<4% of anal canal malignancies
Primary
Secondary Metastasis from cutaneous melanoma (2%)
![Page 5: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/5.jpg)
Epidemiology
Median age at presentation: 55 (range 29-92)
Reported incidence: 0.04 – 1.19%
No adequate population-based studies to draw definite conclusions for racial and gender difference
![Page 6: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/6.jpg)
Presentation
Non-specific symptoms PR bleeding Anal pain, anal mass Tenesmus, pruritus Change in bowel habit
Symptoms of metastatic disease Most common sites of metastases: inguinal / mesenteric /
hypogastric / para-aortic lymph nodes, liver, lung, skin, brain
Weight loss, groin mass, pelvic mass, bowel obstruction
Incidental finding
![Page 7: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/7.jpg)
Presentation
80% lack obvious pigmentation
20% histologically amelanotic
![Page 8: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/8.jpg)
Presentation
Up to 60% with locoregional lymphatic spread (mesorectal, pelvic side wall, inguinal lymph nodes)
Up to 40% with distant metastasis
![Page 9: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/9.jpg)
Investigations
Endoscopy and biopsy
Staging Endoscopic ultrasound: role unclear CT: regional lymphadenopathy, distant metastasis PET scan: may be helpful
![Page 10: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/10.jpg)
Staging
Cutaneous melanoma: AJCC TNM system
ARMM Clinical staging Stage I: local disease Stage II: local disease with regional lymph nodes Stage III: distant metastatic disease
![Page 11: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/11.jpg)
Prognosis
Poor prognosis
Overall 5-year survival 3-22%
Survival <10 months with recurrent or metastatic disease
![Page 12: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/12.jpg)
Prognosis
Good prognostic factors Tumour thickness <2mm
Poor prognostic factors Tumour thickness >3mm Tumour site above dentate line Lymphovascular / perineural invasion Necrosis
Wanebo HJ, Woodruff JM, Farr GH, et al. Anorectal melanoma. Cancer. 1981 Apr 1; 47(7):1891-900.Brady MS, Kavolius JP, Quan SH. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum. 1995 Feb; 38(2):146-51.
Perez DR, Trakarnsanga A, Shia J, et al. Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol. 2013;20:2339-2344.
![Page 13: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/13.jpg)
Treatment
![Page 14: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/14.jpg)
Treatment
Surgery Wide local excision (WLE) Abdominoperineal resection (APR)
Regional lymph node Sentinel lymph node biopsy Lymphadenectomy
![Page 15: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/15.jpg)
Treatment
Adjuvant therapy Systemic
Chemotherapy Biochemotherapy Interferon Vaccine / immunotherapy
Local Radiation therapy Electrochemotherapy
![Page 16: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/16.jpg)
Surgery
Mainstay of treatment
Controversies
① APR vs local excision (LE) APR – en bloc excision with mesorectal lymph nodes ?oncological benefit
② Inguinal lymphadenectomy
![Page 17: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/17.jpg)
Surgery
Meta-analysis by Akihisa Matsuda et al in Annals of Surgery 2014 31 studies 1006 patients APR vs LE
Overall survival Relapse-free survival Local recurrence rate
Akihisa Matsuda, Masao Miyashita, Satoshi Matsumoto, et al. Abdominoperineal Resection Provides Better Local Control But Equivalent Overall Survival to Local Excision of Anorectal Malignant Melanoma – A Systemic Review. Ann Surg. 2014; 00: 1-8.
![Page 18: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/18.jpg)
APR vs LE
Overall survival – no difference (31 studies, N=1006)
![Page 19: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/19.jpg)
APR vs LE
Recurrence-free survival – no difference (14 studies, N=328)
![Page 20: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/20.jpg)
APR vs LE
Local recurrence rate – significantly lower in APR (13 studies)
![Page 21: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/21.jpg)
Surgery
No survival benefit from APR over LE
Higher local recurrence from LE which could be managed by salvage surgery
Less complications and morbidities with LE Better body image Better urinary and sexual function Minimal impact on bowel function
Minimizing morbidities and maximizing quality of life merits consideration in such an aggressive disease
![Page 22: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/22.jpg)
Inguinal lymphadenectomy
Locoregional lymph node metastasis – no significant prognostic implication
Perez DR, Trakarnsanga A, Shia J, et al. Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol. 2013;20:2339-2344.
![Page 23: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/23.jpg)
Inguinal lymphadenectomy
Systemic dissemination with micrometastasis in distant organs occurs early with unfavourable prognosis
Prophylactic – no improvement in survival, increased risk of complications
Therapeutic – seems not to contribute to improvement of survival
Perez DR, Trakarnsanga A, Shia J, et al. Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol. 2013;20:2339-2344.
![Page 24: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/24.jpg)
Adjuvant Therapy
![Page 25: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/25.jpg)
Chemotherapy
Role remains unclear ?Adjuvant ?Palliative
Dacarbazine, cisplatin, vinblastine, vincristine, nimustine, bacillus Calmette-Guérin, levamisole, temozolomide
Single or combination – poor results
![Page 26: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/26.jpg)
Interferon
Interferon alpha Combination of direct activities and indirect immune-
mediated effects Parenteral route / intratumoural injection No standard regimen established Insufficient data
![Page 27: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/27.jpg)
Biochemotherapy
Biologic agent (interferon, interleukin) + traditional cytotoxic chemotherapeutic agent
Longer disease-free and median survival in metastatic ARMM when compared with chemotherapy alone
Kim K B, Sanguino A M, Hodges C, et al. Biochemotherapy in patients with metastatic anorectal mucosal melanoma. Cancer. 2004;100:1478–1483.
Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol. 1999 Jul; 17(7):2105-16.
![Page 28: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/28.jpg)
Biochemotherapy
Role Best available adjuvant therapy after surgery Considered in advanced or metastatic ARMM
![Page 29: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/29.jpg)
Vaccine / Immunotherapy
Immunize against melanoma cell antigen
BRAF and cKIT mutations
Insufficient data
Area of significant research effort and may play an important part of the non-operative treatment of melanoma in the future
![Page 30: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/30.jpg)
Radiation Therapy
Locoregional disease control Primary lesion, inguinal and pericolic lymph nodes
Utility unclear, evidence conflicting
![Page 31: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/31.jpg)
Radiation Therapy
Ballo et al Local excision + post-op RT
Local control rate comparable with APR 5-year local control rate: 74%
No improvement in survival
Moozar et al Pre-op RT little effect on tumour burden Post-op RT did not change local recurrence No survival benefit
Moozar KL, Wong CS, Couture J. Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both. Can J Surg. 2003 Oct; 46(5):345-9.
Ballo MT, Gershenwald JE, Zagars GK, et al. Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol. 2002 Dec 1; 20(23):4555-8.
![Page 32: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/32.jpg)
Electrochemotherapy
Injection of chemotherapy directly into the lesions, followed by application of electric pulses using a needle electrode
Electrical stimulation to the tissues creating a transient permeabilization of the plasma membrane
Allows direct access of the chemotherapeutic agents into the cytosol of tumor cells
Known to provide effective local control for cutaneous melanoma
![Page 33: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/33.jpg)
Electrochemotherapy
Convert APR to sphincter-preserving local excision
Overall success rate unclear
Snoj M, Rudolf Z, Cemazar M, et al. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs. 2005 Mar; 16(3):345-8.
![Page 34: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/34.jpg)
Summary
ARMM is a rare and highly malignant disease
Survival predicted by status of regional and distant metastasis but not method of surgery for local control
Minimizing surgical morbidities and maximizing quality of life should be the major consideration in formulating the treatment plan
Role of all adjuvant therapies is still unclear
![Page 35: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/35.jpg)
References
P Carcoforo, M.T Raiji, G.M Palini, et al. Primary Anorectal Melanoma: An Update. J Cancer. 2012; 3:449-453. doi:10.7150/jca.5187.
Marc Singer and Matthew G. Mutch. Anal Melanoma. Clin Colon Rectal Surg. May 2006; 19(2): 78–87.
Akihisa Matsuda, Masao Miyashita, Satoshi Matsumoto, et al. Abdominoperineal Resection Provides Better Local Control But Equivalent Overall Survival to Local Excision of Anorectal Malignant Melanoma – A Systemic Review. Ann Surg. 2014; 00: 1-8.
Perez DR, Trakarnsanga A, Shia J, et al. Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol. 2013;20:2339-2344.
Wanebo HJ, Woodruff JM, Farr GH, et al. Anorectal melanoma. Cancer. 1981 Apr 1; 47(7):1891-900.
Brady MS, Kavolius JP, Quan SH. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum. 1995 Feb; 38(2):146-51.
![Page 36: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/36.jpg)
References
Kim K B, Sanguino A M, Hodges C, et al. Biochemotherapy in patients with metastatic anorectal mucosal melanoma. Cancer. 2004;100:1478–1483.
Ulmer A, Metzger S, Fierlbeck G. Successful palliation of stenosing anorectal melanoma by intratumoral injections with natural interferon-β. Melanoma Res. 2002;12:395–398.
Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol. 1999 Jul; 17(7):2105-16.
Snoj M, Rudolf Z, Cemazar M, et al. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs. 2005 Mar; 16(3):345-8.
Ballo MT, Gershenwald JE, Zagars GK, et al. Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol. 2002 Dec 1; 20(23):4555-8.
Moozar KL, Wong CS, Couture J. Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both. Can J Surg. 2003 Oct; 46(5):345-9.
![Page 37: A Revisit to Anorectal Malignant Melanoma (ARMM) Joint Hospital Surgical Grand Round 8 Nov 2014 Dr Jessie Chan Pamela Youde Nethersole Eastern Hospital](https://reader036.vdocuments.us/reader036/viewer/2022070409/56649e9d5503460f94b9e4d1/html5/thumbnails/37.jpg)
Thank You